day 1 agenda
4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA |
|
Sep 13 - 14, 2023 at Barcelona, Spain | |
SCIENTIFIC PROGRAM | |
Day 1 - September 13, 2023 Hall -Sitges |
|
07:45-08:45 | Registrations Open |
08:45-09:00 | Welcome remarks by Moderator |
Keynote Talks | |
09.00-09.30 | Title: Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid (beta) |
Martin Bachmann, University of Bern,Switzerland | |
09:30-10:00 | Title: House as Carer: enabling older adults with Dementia to live at Home |
Masi Mohammadi, Eindhoven University of Technology, The Netherlands | |
10.00-10.30 | Title: The Italian INTERCEPTOR project |
Paolo M. Rossini, Catholic University in Rome, Itlay | |
10:30-10:50 | Group Photo & Refreshment Break @ Foyer |
Alzheimer's Research and Therapy & Advances in Alzheimer’s and Dementia Research |
|
Session Chairs: Dr. Paolo M. Rossini & Dr. Gerard Griffioen | |
10-50-11:10 | Title: Intranasal Dantrolene Nanoparticle As A Disease-Modifying Drug For Treatment of Alzheimer’s Disease |
Huafeng Wei, University of Pennsylvania, USA | |
11:10-11:30 | Title: Non-Invasive Neurostimulation in Home Settings for Cognitive Enhancement in Mild to Moderate Alzheimer’s Disease |
Helena Knotkova, MJHS Institute for Innovation in Palliative Care,USA | |
11:30-11:50 | Title: Neuromodulation for word finding in logopenic primary progressive aphasia secondary to Alzheimer’s disease: A subphonemic analysis |
Tifani Biro, University of Pennsylvania,USA | |
11:50-12:10 | Title: Organ on a chip in vitro model in Alzheimer disease |
Monica Mir, University of Barcelona,Spain | |
12:10-12:30 | Title: GHS-R1a deficiency rescues memory decline in AD model mice |
YU ZHOU, University of Health and Rehabilitation Sciences,China | |
12:30-12:50 | Title: Life span changes in the CD4 T-cell compartment and their impact on aging and disease |
Alon Monsonego, Ben-Gurion University, Israel. | |
12:50-14:00 | Lunch Break @ Restaurant |
Session Chairs: Prof .Jacques P. Tremblay & Prof. Maria Carla Tesi |
|
14:00-14:20 | Title: Neuroprotective Features of angiotensin receptor blockers in Preclinical Alzheimer’s mouse models |
Lusine Danielyan, University Hospital of Tuebingen, Tuebingen, Germany | |
14:20-14:40 | Title: The synergistic interplay between amyloid beta and tau in Alzheimer’s disease: a mathematical model on the human connectome |
Maria Carla Tesi, University of Bologna,Itlay | |
14:40-15:00 | Title: AUTOTAC (AUTOphagy-TArgeting Chimera): Targeted degradation of tau tangles in Alzheimer’s disease via the autophagy-lysosome system |
Yong Tae Kwon, Seoul National University, Seoul, Korea | |
15:00-15:20 | Title: Neuroprotection in Alzheimer’s disease by restoring intraneuronal calcium homeostasis |
Gerard Griffioen,reMYND N.V, Belgium | |
15:20-15:40 | Title:National Institute on Aging Seed Funding enables Alzheimer’s disease startups to reach key value inflection points |
Armineh L Ghazarian, National Institute on Aging,USA | |
15:40-16:00 | Title: Insertion of the Icelandic mutation (A673T) in the APP gene using the CRISPR/Cas9 base editing and Prime editing technologies, a preventive treatment for Alzheimer? |
Jacques P. Tremblay, Laval University, Canada | |
16:00-16:20 | Refreshment Break @ Foyer |
16:20-16:40 | Title:A Psychiatric Perspective on the Neuropsychiatric Symptoms in Dementia |
Arushi Kapoor, University of Pennsylvania, USA | |
16:40-17:00 | Title: Frontotemporal brain sagging syndrome |
Luis Alberto Ortega-Porcayoa, HOSPITAL ANGELES PEDREGAL,Mexico | |
17:00-17:20 | Title: Consensus recommendations on Epilepsy in Phelan-McDermid syndrome |
Sarah Jesse, ULM University, Germany | |
Day 1 Concludes |
day 2 agenda
4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA |
|
Day-2 (September 14, 2023) Hall- Sitges |
|
Moderator: Memoona Hasnain, USA | |
Keynote Talk | |
09:00-09:30 | Title: Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease |
David St Clair, University of Aberdeen, UK | |
Technical session-II | |
Vascular Dementia, Aging and Dementia & Molecular and Cell Biology, Risk reduction and prevention |
|
Session Chairs: Dr. Masi Mohammadi & Dr. Zixu Mao |
|
09:30-9:50 | Title: White matter mechanisms in a spontaneous mouse model of chronic mild hypoperfusion with eNOS deficiency |
Francesca-Fang Liao, University of Tennessee Health Science Center,USA | |
09:50-10:10 | Title:Nutrition and Memory Brain Health |
Gunjan Khera,United Arab Emirates University, UAE | |
10:10-10:30 | Title: Age of onset influences stigmatic attributions towards a person with dementia |
Lilach Raviv Turgeman, Zefat Academic College, Zefat, Israel | |
10:30- 10:50 | Refreshment Break @ Foyer |
10:50-11:10 | Title: Screening of pathogenic variants in eight Alzheimer’s disease related genes in Bulgarian patients by pooled whole-exome sequencing |
Sena Karachanak-Yankova,Medical University of Sofia, Sofia, Bulgaria | |
11:10-11:30 | Title:Study the Therapeutic Benefit of Commercial Coffees for AD in N2a/APPswe Cell Model |
Chuanhai Cao,University of South Florida, USA | |
11:30-11:50 | Title: Dysfunction of miRNA biogenic machinery in neuronal stress and Alzheimer’s disease |
Zixu Mao, Emory University School of Medicine, USA | |
11:50-12:10 | Title: Concerted role of CX3CL1 and proteases in Alzheimer’s disease “in vitro” and “in vivo” |
Giulio Ghersi & Matilda Iemmolo,University of Palermo, Palermo, Italy | |
12:10-12:30 | Title: Intermittent Fasting as a Potential Preventative Treatment for the Progression from Type II to Type III Diabetes (Alzheimer's Disease) |
Joseph M. Schulz , University of Miami , USA | |
12:30-12:50 | Title:Economics of the community mechanism: applications to communities in which some members have dementia |
Masao Ogaki, Keio University, Japan | |
12:50-14:00 | Lunch Break @ Restaurant |
Technical session-III | |
Dementia care research and Practice, Dementia diagnosis, treatment & Living with Alzheimer’s & Dementia: The Experiences |
|
Session Chairs Dr.Erwin L. Roggen & Dr. Valerie Gruss |
|
14:00-14:20 | Title: Search for miRNAs implicated in a putative Adverse Outcome Pathway (AOP) with the potential to predict sporadic Alzheimer’s disease inn the preclinical phase. |
Erwin L. Roggen, ToxGenSolutions, Maastricht, Netherlands | |
14:20-14:40 | Title: The results of dementia community care implementation in rural area of Eastern Taiwan |
Wenting Tseng, Mennonite Hospital Shou_feng Branch, Hualien County, Taiwan | |
14:40-15:00 | Title:The future of aging: Utilizing mobile technology to educate the public about Alzheimer’s Disease |
Valerie Gruss & Memoona Hasnain, University of Illinois at Chicago,USA | |
Poster Presentation | |
15:00-15:15 | Title: Neurocognitive dysfunction among type 2 diabetes patients attending primary health care in Jeddah, Saudi Arabia |
Alshaymaa A. Alshaikh, NGH, Saudi Arabia | |
15:15-15:30 | Refreshment Break @ Foyer |
Conference Ends |
posters agenda
posters will be updated soon.
posters agenda
4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA(Virtually through Zoom) | |
Sep 13, 2023 (CEST -Barcelona Time) | |
11:00-11:20 | Title: Sleep, physical activity, sedentary behavior, and risk of incident dementia: a prospective cohort study of 431,924 UK Biobank participants |
Shuyi Huang, Fudan University, China | |
11:20-11:40 | Title: The effect of perceived threat avoidability of COVID-19 on coping strategies and psychic anxiety among Chinese college students in the early stage of COVID-19 pandemic |
Wenpei Zhang, Anhui University of Technology, China | |
11:40-12:00 | Title:Vietnamese Version of Cornell Scale for Depression in Dementia at an Outpatient Memory Clinic: A Reliability and Validity Study |
Tan Thanh Huynh,Pham Ngoc Thach University of Medicine, Vietnam | |
12:00-12:30 | Keynote: Microbiota changes associated with Alzheimer’s disease risk factors: indicators for protective treatments |
Illana Gozes,Tel Aviv University, Israel | |
12:30-12:50 | Title: Neutralization of Interleukin-17 (IL-17) ameliorates systemic inflammation and peripheral vascular dysfunction associated to Alzheimer’s disease |
Valentina Vellecco, University of Naples Federico II, Italy | |
12:50-13:10 | Title: A new prototype of an antiepileptic drug acts mainly at the posttranslational level on a model of maximum electroshock in mice |
Artem I.Davletshin, Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, Russia | |
13:10-13:40 | Keynote: Neurophysiological Approach by Self-Control of your Stressrelated Autonomic Nervous System |
Kees Blase, National Centre Stress management, Netherlands | |
13:40-14:10 | Keynote: Is Alzheimer’s disease a disease? |
Amos D Korczyn, Tel Aviv University, Israel | |
14:10-14:30 | Title: Alzheimer’s Disease: Beyond Neuroinflammation and Immunosenescence |
Stephan Chee, NHS, UK | |
14:30-14:50 | Title: How Special care units could support narrativity? |
Valentin INSARDI, University of Strasbourg, France | |
14:50-15:10 | Title: Association Between Cognitive Impairment and Motor Dysfunction in Patients with Multiple Sclerosis: A Cross-sectional Study |
Hanadi Matar Alharthi, King Saud University Medical City, Saudi Arabia | |
15:10-15:30 | Title: Barriers and facilitators to adherence to exercise groups amongst the population of older people living with dementia in the community |
Rosaria Gracia, The Open university, UK | |
15:30-15:50 | Title: Sympathetic Hyperactivity and its Degenerative Consequences in Stem Cell and Mouse Models of Familial Dysautonomia |
Nadja Zeltner,University of Georgia, USA | |
15:50-16:10 | Title: Down syndrome and dementia: cognitive measurement and monitoring |
Jordan Harp,University of Kentucky College of Medicine, USA | |
16:10-16:30 | Title: Super-resolution neural network-driven mouse cerebrovascular mapping with MION-based MRI |
Xiaoqing Alice Zhou, Harvard Medical School, USA | |
16:30-16:50 | Title: A peptide blocking the ADORA1-neurabin interaction is anticonvulsant and inhibits epilepsy in an Alzheimer’s model |
Qin Wang,Medical College of Georgia at Augusta University, USA | |
16:50-17:10 | Title: A novel strategy for Alzheimer’s disease treatment using blood/plasma exchange |
Claudio Soto, University of Texas Health Science Center at Houston, USA | |
17:10-17:30 | Title: Utilizing Timed Categorical Recall (naming U. S. cities) for Rapid Bedside Dementia Screening |
Charles R. Joseph, Liberty University College of Osteopathic Medicine, USA | |
17:30-17:50 | Title: Clinical Development of a Novel Synaptogenic Molecule to treat Alzheimer’s and other Neurodegenerative Diseases |
Vincent F. Simmon, Spinogenix, Inc.USA | |
17:50-18:10 | Title: APOE genotype mediates differential alterations in HDL particle size distribution and function in patients with Alzheimer’s and mild cognitive impairment vs. controls |
Angela M. Zivkovic, University of California, USA | |
18:10-18:30 | Title: Interferon-induced protein in HIV-1 Associated Neurocognitive Disorders (HAND) and Alzheimer's Disease Pathology |
Upal Roy, The University of Texas Rio Grande Valley, USA | |
Day-1 Concludes | |
4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA(Virtually through Zoom) | |
Sep 14, 2023 (CEST -Barcelona Time) | |
13:30-13:50 | Title: Modelling thermal comfort of older people with dementia living in care homes: an evaluation of heat balance, adaptive comfort and thermographic methods |
Choo-yoon Yi, The University of Sheffield, UK | |
13:50-14:10 | Title: Transcriptomic Profiling reveals the key role of the HDAC1 gene in Frontotemporal Dementia |
Amaan Arif, Amity University Uttar Pradesh, India | |
14:10-14:30 | Title: Palliative care in advanced Alzheimer's disease dementia: evaluation of the answers given by caregivers to the accuracy of surprise question, as a prognostic tool. |
Erika Kiyomi Yuyama ,Federal University of Uberlandia, Brazil | |
14:30-14:50 | Title: Contributors to cognitive decline in adults |
Graeme Peterson, Harvard University, USA | |
14:50-15:10 | Title: Something New from Something Old:The Stages of Objective Memory Impairment (SOMI) System |
Ellen Grober, Albert Einstein College of Medicine, USA | |
15:10-15:30 | Title: Alzheimer’s Drugs: Beyond Antibodies |
Suren A.Tatulian, University of Central Florida, USA | |
15:30-15:50 | Title: Natural α-galactoside- and β-glucoside-specific antibody immune complexes bound to surface O-glycoproteins of circulating platelets prevent aggregation, but dislodge at diabetic glucose levels |
Karthi Sreedevi, Sree Chitra Tirunal Institute for medical sciences and technology, India | |
15:50-16:10 | Title: Transcranial photobiomodulation to improve cognition and behavior/mood in ex-football players with possible chronic traumatic encephalopathy; improved functional connectivity and NAA levels on MRI |
Margaret A. Naeser, Veterans Affairs Boston Healthcare System, Boston University School of Medicine, USA | |
16:10-16:30 | Title: Synergistic influence of cytokine genes polymorphisms over the risk of dementia. A Multifactor Dimensionality Reduction Analysis. |
Teresa Juarez-Cedillo,Mexican Social Security Institute, Mexico | |
16:30-17:00 | Keynote: “Understanding & Curing Age-Related Neurologic Disease” |
Michael Fossel,Telocyte LLC, USA | |
17:00-17:20 | Title: DYRK1A-interacting proteins, a link between Down's syndrome and its comorbidities |
Janel Nathalie,Paris City University, France | |
17:20-17:40 | Title: What we know about recognizing older adults who are missing |
Vicki S.Gier, Mississippi State University-Meridian Campus, USA | |
17:40-18:00 | Title: "Strategic Advance Care Planning”: a protocol that defines success as physicians/providers honoring patients’ wishes |
Stanley A Terman, Caring Advocates, USA | |
18:00-18:20 | Title: Federated Deep Learning for Detecting Alzheimer’s Disease in Multi-Cohort Brain MRI |
Dimitris Stripelis, University of Southern California, USA | |
Day-2 Concludes |